The newly launched next-gen device includes a redesign intended to improve ease of placement and stability, and is available in longer sling lengths, the Marlborough, Mass.-based company said.
“I believe the Advance XP Male Sling will allow my patients to get back to their normal, daily activities sooner. The modifications may help reduce post-operative sling slippage and may reduce the restrictions I previously placed on my patients immediately following placement, such as lifting, squatting and sexual activity,” Dr. Brian Christine of the Urology Centers of Alabama said in a press release.
Boston Scientific said that it worked with urologists to improve the platform and allow physicians to treat more patients with the sling device. The device includes a chevron anchoring mechanism intended to enhance tissue fixation and changes to its mesh weave to provide uniform load displacement, the company said.
“The U.S. launch of the AdVance XP Male Sling is another example of how Boston Scientific continues to proactively identify physician needs and innovate to meet them while improving patients’ lives. Now, more patients with mild to moderate stress urinary incontinence can receive treatment. We are proud to be able to offer this device to appropriate patients to help them return to a sense of normalcy,” pelvic health GM Jeannette Bankes said in a prepared statement.
Early last week, Boston Scientific saw shares rise after the medical device maker posted fourth quarter and full year 2018 earnings that topped consensus on Wall Street.